European Commission Approves Fycompa® (Perampanel) For Partial-onset Seizures
European Commission (EC) has issued Marketing Authorisation Approval for the use of Fycompa® (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised…